Skip to main content
. Author manuscript; available in PMC: 2022 May 6.
Published in final edited form as: Travel Med Infect Dis. 2019 Jan 14;27:20–26. doi: 10.1016/j.tmaid.2019.01.008

Table 2.

Summary of proportions of adverse outcomes reported for atovaquone-proguanil and proguanil.

Summary of adverse outcomes by drug

Atovaquone-Proguanil Proguanil

Miscarriage Stillbirth Early Death Congenital Anomaly Miscarriage Stillbirth Early Death Congenital Anomaly

n/N Percentage (95% CI) 21/260 8.08 (5.07, 12.08) 1/95 1.05 (0.03, 5.73) 0/48 0 (0, 7.4) 11/430 2.56 (1.28, 4.53) 23/907 2.53 (1.61, 3.78) 2/427 0.47 (0.06, 1.68) 31/515 6.02 (4.13, 8.43) 15/331 4.53 (2.56, 7.36)